Alessia Levaggi

Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer

Lucia Del Mastro, Luca Boni, Andrea Michelotti et al. · JAMA · 2011 · 346 citations

Medicine, Endocrinology, Oncology +13

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival

Matteo Lambertini, Luca Boni, Andrea Michelotti et al. · JAMA · 2015 · 204 citations

Medicine, Endocrinology, Oncology +17

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes

Giuseppe Canavese, Béatrice Dozin, C Vecchio et al. · European Journal of Surgical Oncology · 2011 · 53 citations · Full text

Medicine, Oncology, Pathology +17

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

Lucia Del Mastro, Francesca Poggio, Eva Blondeaux et al. · The Lancet Oncology · 2022 · 50 citations

Medicine, Oncology, Pharmacology +12